Gene · 917
Papers1,874
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 1,874
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Molecular Dynamics-Based Design and Biophysical Evaluation of Thermostable Single-Chain Fv Antibody Mutants Derived from Pharmaceutical Antibodies. | ACS Omega | 2023 | 37396255 | PubTator, text mining | PubMed |
| Differentiation of IL-26+ TH17 intermediates into IL-17A producers via epithelial crosstalk in psoriasis. | Nat Commun | 2023 | 37391412 | PubTator, text mining | PubMed |
PTPRC promoted CD8+ T cell mediated tumor immunity and drug sensitivity in breast cancer: based on pan-cancer analysis and artificial intelligence modeling of immunogenic cell death-based drug sensitivity stratification. | Front Immunol | 2023 | 37388747 | PubTator, text mining | PubMed |
| MultiVI: deep generative model for the integration of multimodal data. | Nat Methods | 2023 | 37386189 | PubTator, text mining | PubMed |
| Screening biomarkers for Sjogren's Syndrome by computer analysis and evaluating the expression correlations with the levels of immune cells. | Front Immunol | 2023 | 37383223 | PubTator, text mining | PubMed |
| Severe Combined Immunodeficiency-Classification, Microbiology Association and Treatment. | Microorganisms | 2023 | 37375091 | PubTator, text mining | PubMed |
| Intrinsic Immunogenic Tumor Cell Death Subtypes Delineate Prognosis and Responsiveness to Immunotherapy in Lung Adenocarcinoma. | Biology (Basel) | 2023 | 37372093 | PubTator, text mining | PubMed |
| Central role of lung macrophages in SARS-CoV-2 physiopathology: a cross-model single-cell RNA-seq perspective. | Front Immunol | 2023 | 37350967 | PubTator, text mining | PubMed |
The Impact of Tumor Cell-Intrinsic Expression of Cyclic GMP-AMP Synthase (cGAS)-Stimulator of Interferon Genes (STING) on the Infiltration of CD8+ T Cells and Clinical Outcomes in Mismatch Repair Proficient/Microsatellite Stable Colorectal Cancer. | Cancers (Basel) | 2023 | 37345163 | PubTator, text mining | PubMed |
| HOPX is a tumor-suppressive biomarker that corresponds to T cell infiltration in skin cutaneous melanoma. | Cancer Cell Int | 2023 | 37344870 | PubTator, text mining | PubMed |
| The current advances of lncRNAs in breast cancer immunobiology research. | Front Immunol | 2023 | 37342324 | PubTator, text mining | PubMed |
| Transcriptomic classes of BCR-ABL1 lymphoblastic leukemia. | Nat Genet | 2023 | 37337105 | PubTator, text mining | PubMed |
| A unique expression pattern of LAG3 distinct from that of other immune checkpoints in diffuse large B-cell lymphoma. | Cancer Med | 2023 | 37326144 | PubTator, text mining | PubMed |
| PD1hi CD200hi CD4+ exhausted T cell increase immunotherapy resistance and tumour progression by promoting epithelial-mesenchymal transition in bladder cancer. | Clin Transl Med | 2023 | 37313656 | PubTator, text mining | PubMed |
| Identification of a novel signature based on macrophage-related marker genes to predict prognosis and immunotherapeutic effects in hepatocellular carcinoma. | Front Oncol | 2023 | 37305578 | PubTator, text mining | PubMed |
| Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD. | Cancers (Basel) | 2023 | 37296834 | PubTator, text mining | PubMed |
| Identification and validation of subclusters of papillary thyroid carcinoma based on Human Phenotype Ontology. | Gland Surg | 2023 | 37284705 | PubTator, text mining | PubMed |
| A novel T-cell exhaustion-related feature can accurately predict the prognosis of OC patients. | Front Pharmacol | 2023 | 37284314 | PubTator, text mining | PubMed |
| Machine learning-based solution reveals cuproptosis features in inflammatory bowel disease. | Front Immunol | 2023 | 37275904 | PubTator, text mining | PubMed |
| The increased cfRNA of TNFSF4 in peripheral blood at late gestation and preterm labor: its implication as a noninvasive biomarker for premature delivery. | Front Immunol | 2023 | 37275889 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/917/papers?page=13